Megalin, a 600-kDa glycoprotein and member of the low-density lipoprotein receptor family, is internalized by endocytosis to form endocytic vesicles and then recycled to the plasma membrane 5, 6 . Endocytic ligands of megalin, including 25(OH)D-DBP complexes, are trafficked to lysosomes for degradation, during which 25(OH)D escapes from the pathway and is transported to mitochondria for conversion to 1,25(OH) 2 D or 24,25(OH) 2 D [5] [6] [7] .
Megalin exists in urine in both ectodomain (A-megalin) and full-length (C-megalin) forms, which can be measured using amino-and carboxyl-terminal enzyme-linked immunosorbent assay (ELISA) results, respectively 8 . Using those assays, Saito and colleagues found that urinary C-megalin is increased along with the progression of diabetic kidney disease 8 and IgA nephropathy 9 . Also, De et al. recently showed that urinary C-megalin excretion is increased via exocytosis from PTECs injured by endo-lysosomal overload caused by megalin-mediated protein metabolism 10 . The clinical significance of urinary C-megalin, which represents "metabolic nephron load, " was confirmed by results showing that it is also a good marker to diagnose pediatric patients with renal scarring, which often occurs following a febrile urinary infection and is often accompanied by residual nephron overload 11 . Therefore, urinary C-megalin excretion likely reflects phenotypic changes that progress in PTECs in CKD patients 12 . The expression and function of megalin in PTECs are considered to be affected by progression of CKD 13, 14 . Therefore, increased exosome megalin loss may be associated with a decrease in its renal expression and altered function for vitamin D handing, providing insight into the mechanisms underlying vitamin D metabolism in affected patients.
With that background in mind, the aim of the present study was to determine the significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.
Results
Clinical characteristics of CKD patients. The clinical characteristics of the 153 CKD patients enrolled in the present study are shown in Table 1 . Values for median eGFR, corrected calcium (cCa), and phosphate (Pi) were 30.0 (5.0-58.8) mL/min/1.73 m 2 , 9.4 (6.7-10.7) mg/dL, and 3.6 (2.0-7.2) mg/dL, respectively, while those for whole parathyroid hormone (wholePTH) and fibroblast growth factor (FGF) 23 in serum were 49.4 (6.8-645 .0) pg/mL and 77.5 (10.0-840.0) pg/mL, respectively, well above their respective normal upper limits 15, 16 . Additionally, urinary C-megalin was 0.6 (0-8.5) pmol/g Creatinine (Cr), higher than the reported value for healthy individuals (0.15 pmol/g Cr, n = 160) 8, 9 .
Relationship of urinary excreted β 2 -microglobulin (β 2 MG) and α 1 -microglobulin (α 1 MG) with urinary C-megalin excretion in CKD patients. To examine whether urinary C-megalin excretion might be a clinically relevant assay factor for PTECs injury, relationships between urinary C-megalin excretion with urinary of β 2 MG and α 1 MG, which are established markers for PTECs dysfunction and endocytic ligands of megalin in PTECs 14 , were investigated. We compared those markers after stratification of β 2 MG/Cr and α 1 MG/Cr in 153 CKD patients by quintiles (Fig. 1 ). Urinary C-megalin excretion became significantly greater in quintiles with higher levels of either urinary excretion of β 2 MG/Cr (p < 0.001) or α 1 MG/Cr (p < 0.001), indicating that urinary C-megalin excretion is a relevant marker for PTECs injury and linked with the endocytic function of megalin in CKD patients.
No. of patients 153
Age, years (range) 67 (26- Univariate and multivariate analyses of associations of various clinical variables with urinary C-megalin in CKD patients. Among the various clinical variables subjected to univariate analysis of correlation with urinary C-megalin excretion in the present CKD patients, serum levels of wholePTH (ρ = 0.224, p = 0.007) and FGF23 (ρ = 0.280, p < 0.001), and urinary levels of protein/Cr (ρ = 0.603, p < 0.001), β 2 MG/Cr (ρ = 0.415, p < 0.001), and α 1 MG/Cr (ρ = 0.594, p < 0.001) showed significantly positive correlations with urinary C-megalin excretion, whereas Body Mass Index (BMI) (ρ = -0.186, p = 0.033), serum albumin (ρ = -0.391, p < 0.001), and eGFR (ρ = -0.389, p < 0.001) had significantly negative correlations (data not shown). These findings were then further examined using multiple regression analysis (Table 2) . When age, gender, BMI, HbA1c, albumin, log(eGFR), log(wholePTH), log(FGF23), and log(1 + urinary protein/Cr) were included as independent variables (model 1), log(1 + urinary protein/Cr) emerged as significant independent factors positively associated with urinary C-megalin. When urinary log(1 + urinary protein/Cr) was replaced with log(urinary β 2 MG/Cr) (model 2) or log(urinary α 1 MG/Cr) (model 3), those factors also showed a significant and independent association with urinary C-megalin. Analyses with models 4 and 5, which included urinary log(1 + urinary protein/Cr) together with log(urinary β 2 MG/Cr) or log(urinary α 1 MG/Cr), respectively, each demonstrated urinary log(1 + urinary protein/Cr) as a significant independent factor associated with urinary C-megalin. Notably, neither log(wholePTH) nor log(FGF23) was found to be associated with urinary C-megalin.
Correlations of serum vitamin D metabolites with eGFR in CKD patients. As we previously reported (Fig. 2D,E) .
Correlations of serum vitamin D metabolites with urinary C-megalin excretion in CKD patients. We next examined the correlation of urinary C-megalin excretion with the serum vitamin D metabolites 25(OH)D (Fig. 3A) , 1,25(OH) 2 D (Fig. 3B) , and 24,25(OH) 2 D (Fig. 3C) . Those results showed that each was significantly correlated in a negative manner (r = −0.292, p < 0.001, r = −0.223, p = 0.007 and r = −0.293, p < 0.001, respectively) with urinary C-megalin excretion in the present 153 CKD patients. These findings indicate that urinary loss of megalin via exosomes is associated with reduced serum levels of vitamin D metabolites in CKD. Table 2 . Multiple regression analysis of association with log(1 + urinary C-megalin/Cr). β is the standardized regression coefficient. *p < 0.05. BMI = body mass index, HbA1c = hemoglobin A1c, Alb = albumin, eGFR = estimated glomerular filtration rate, PTH = parathyroid hormone, FGF23 = fibroblast growth factor 23, MG = microglobulin.
Scientific . Those correlations were further examined using multiple regression analysis (Table 3) . When age, gender, BMI, HbA1c, albumin, log(eGFR), log(wholePTH), log(FGF23), and log(1 + urinary C-megalin/Cr) were included as independent variables (model 1), log(1 + urinary C-megalin/Cr) in addition to female gender, and log(wholePTH) emerged as significant independent factors negatively associated with serum 25(OH)D. When urinary log(1 + urinary C-megalin/Cr) was replaced with urinary log(1 + urinary protein/Cr) (model 2), log(1 + urinary protein/Cr) was shown to have a significantly negative association with serum 25(OH)D. In analysis with model 3, which simultaneously included urinary log(1 + urinary C-megalin/Cr) and log(1 + urinary protein/Cr), log(1 + urinary C-megalin/Cr), but not log(1 + urinary protein/Cr), retained a significantly negative association with serum 25(OH)D. It is also important to note that serum wholePTH correlated significantly in a negative manner with 25(OH)D (ρ = −0.190, p = 0.028), and that multivariate regression analysis showed that serum wholePTH retained a significantly negative association with serum 25(OH)D in models 1, 2, and 3 ( Table 3) .
Associations of serum vitamin D metabolites and their ratios in serum wholePTH and FGF23 quintiles. To determine the significance of the effect of wholePTH on vitamin D metabolism in CKD patients, we examined serum 25(OH)D (Fig. 4A) (Table 4) . When age, gender, BMI, HbA1c, serum albumin, log(eGFR), log(wholePTH), log(FGF23), and log(1 + urinary C-megalin/Cr) were included as independent variables, log(eGFR) was significantly and positively associated with serum log . Differences between quintiles were examined by one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, as compared with Q1 using Dunnett's test.
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Discussion
Results in the present study of 153 pre-dialysis CKD patients indicate that determination of urinary C-megalin excretion is clinically relevant for assessment of PTECs injury. That is based on its good correlation with urinary excretion of β 2 MG/Cr and α 1 MG/Cr (Fig. 1) , and our finding that urinary loss of C-megalin might cause a reduction of serum 25(OH)D, based on its negative association with serum 25(OH)D (Table 3) . Furthermore, it is likely that urinary C-megalin loss may also be involved in reductions of serum 1,25(OH) 2 D, and 24,25(OH) 2 D (Fig. 3) The present findings also revealed a significant and positive correlation of urinary protein with urinary C-megalin (Table 2) . That finding is quite reasonable, since increased glomerular filtration of proteins, such as albumin and other low molecular weight proteins, which are taken up by PTECs via megalin, likely overloads the cellular endo-lysosomal system, leading to increased urinary C-megalin excretion by exocytosis from injured PTECs 10 . On the other hand, urinary C-megalin excretion, but not urinary protein excretion, was found to have a significantly negative association with serum 25(OH)D in a manner independent of eGFR, wholePTH, and FGF23 (Table 3) . Interestingly, it has been speculated that renal dysfunction may accelerate vitamin D , while wholePTH and FGF23 are considered to stimulate degradation of 25(OH)D to dihydroxyvitamin D metabolites [22] [23] [24] [25] . However, megalin-mediated protein metabolic load to PTECs caused by increased glomerular protein filtration may surpass the endocytic capacity of megalin, leading to overflow of 25(OH)D-DBP complexes into urine, possibly resulting in an association of urinary C-megalin excretion with serum 25(OH)D level. Furthermore, protein metabolic load-induced phenotypic changes in PTECs 12 may alter intracellular trafficking of 25(OH)D to mitochondria or have an effect on its manner of activation.
It is interesting to note that serum wholePTH, but not FGF23, was associated in a significantly negative manner with serum 25(OH)D (Table 3 ). The present study showed that serum wholePTH associated in a negative manner with serum 25(OH)D, which was in good agreement with our previous study that serum PTH increases as serum 25(OH)D level decreases 26, 27 . Therefore, reduced serum 25(OH)D due to impaired megalin-mediated absorption of 25(OH)D-DBP complexes may be responsible, at least in part for development of hyperparathyroidism as indicated by the finding of increased wholePTH, based on the suppressive effect of 25(OH)D on PTH synthesis at parathyroid gland 28 . Therefore, it is possible that urinary exosome megalin excretion has an influence to increase serum PTH, which stimulates 25(OH)D metabolism to 1,25(OH) 2 D, as compared to the effect of FGF23 to stimulate 25(OH)D metabolism to 24,25(OH) 2 D in CKD patients. Since the eGFR values of the present CKD patients were distributed between 5.0 and 58.8 mL/min/1.73 m 2 , it is reasonable to speculate that 25(OH) D metabolism is heavily affected by secondary hyperparathyroidism, based on our results indicating that serum PTH starts to increase at a level below 50 mL/min/1.73 m 2 and then in an eGFR-dependent manner thereafter 26 . The lack of association between eGFR and 25(OH)D shown in the present study (Table 3) 34 and rats 35, 36 . Therefore, it is unlikely that the site of activation of 25(OH)D to 1,25(OH) 2 D might be too severely damaged to produce 1,25(OH) 2 The present study has several limitations. First, the number of patients examined was relatively few, mainly because we enrolled those consecutively examined at a single institution. Another limitation is that the present cross-sectional study was limited to Japanese CKD patients and it remains unclear whether the results obtained can be extended to other ethnicities. Furthermore, as shown in Fig. 2, serum 25 (OH)D levels were rather low in our Japanese population, because of the relatively low level of intake of dairy products and absence of vitamin D-fortified foods. Also, it was not possible to assess causality because of the cross-sectional design. A cohort survey of disease occurrence is necessary to directly evaluate the causality of megalin and its clinical effects on vitamin D metabolites.
In 
Methods
Ethics statement. This study was approved by the Ethics Committee of Osaka City University Graduate School of Medicine (approval #3366). All study participants provided written informed consent for sampling of blood and urine, as well as examinations of clinical records. The research was done in accordance with the Declaration of Helsinki.
Subjects. CKD was defined by criteria proposed by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 39 . Among CKD patients regularly followed by nephrologists at the Department of Nephrology at Osaka City University Hospital, 153 examined from April to June 2017 were enrolled in the present study. The primary conditions related to CKD in our patients were hypertensive nephrosclerosis (n = 45), diabetic nephropathy (n = 26), IgA nephropathy (n = 19), membranous nephropathy (n = 17), autosomal dominant polycystic kidney disease (n = 12), focal and segmental glomerulosclerosis (n = 5), myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis (n = 4), membranoproliferative nephropathy (n = 2), minimal change nephrotic syndrome (n = 1), and unknown (n = 22). Patients with advanced liver disease or taking vitamin D supplements or drugs known to affect vitamin D metabolism including vitamin D derivatives were excluded.
Measurements. Blood and urine samples were collected from all subjects in the morning after overnight fasting. Urine samples were kept on ice for 1 hour and then centrifuged at 1500 rpm for 10 minutes, as previously described 40, 41 . All laboratory measurements were performed using routine assays with automated methods 19, 26, 42 . eGFR was calculated using the new Japanese coefficient for the abbreviated Modification of Diet in Renal Disease Study equation, including a correction factor for women of 0.739 43 . Serum calcium was corrected based on serum albumin, which was calculated as corrected calcium (cCa), as previously reported 26 . Serum wholePTH, which reacts with biologically active full-length PTH (1-84), was measured using a wholePTH assay (Scantibodies Laboratory, Inc. Santee, CA), which is a two-site immunoradiometric assay that exclusively measures PTH (1-84), with intra-and coefficients of variation (CVs) less than 2.3-6.1% and 2.9-8.9%, respectively 15, 26, 44, 45 . Serum FGF23 was determined using a fully automated random access chemiluminescence immunoanalyzer device, the CL-JACK System [Kyowa Medex Co. Ltd., Tokyo, Japan; intra-assay CV 2.7-3.4%, inter-assay CV 1.9-6.3% (internal data)] 16, 19 . Serum levels of vitamin D metabolites were determined as noted in previous studies 1, 15, 26 . Briefly, serum 1,25(OH) 2 D was measured using a 1,25(OH) 2 D RIA kit (Immunodiagnostic Systems Limited, Boldon, England), and serum 25(OH)D and 24,25(OH) 2 D with a modified HPLC-tandem mass-mass spectrometry method with atmospheric pressure chemical ionization (LC-APCI-MS/MS) (HPLC System; Shimadzu, Kyoto, Japan; LC-APCI-MS/MS System; Applied Biosystems, Foster City, CA). The intra-and inter-assay CVs were 3.4-9.2% and 11.9%, respectively, for measurement of 25(OH)D, and 13.1-19.3% and 14.7%, respectively, for measurement of 24,25(OH) 2 D 1, 19, 46, 47 . Quantification of urinary C-megalin was performed as previously described 8, 9 . Briefly, 90 μL of urine was mixed with 10 μL of a solution containing 2 mol/L Tris-HCl, 0.2 mol/L EDTA, and 10% Triton X-100 (pH 8.0), then incubated for 1 minute at room temperature, followed by reactions between the captured monoclonal antibodies immobilized on ELISA plates and the carboxy-terminal domain of megalin. An alkaline phosphatase-labeled tracer monoclonal antibody was then added to the plate and measurements were conducted using a chemiluminescent immunoassay detection system. As surrogate markers of renal tubule injury, urinary concentrations of Cr, β 2 MG, and α 1 MG were determined using an automated instrument (7170 S; Hitachi High-Technologies Corp., Tokyo, Japan), with CRE-S (Denka Seiken Co., Ltd.), BMG-Latex (Denka Seiken Co., Ltd.), and αMi-Latex (Denka Seiken Co., Ltd.) kits, respectively, as previously described 8, 9 . The urinary concentration of each marker was normalized to that of Cr, then expressed as g/g Cr (protein), µg/g Cr (β 2 MG), mg/g Cr (α 1 MG), and pmol/g Cr (C-megalin). 48, 49 . Association between urinary C-megalin and quintiles of β 2 MG or α 1 MG values were analyzed by one-way ANOVA (analysis of variance), followed by Dunnett's test. Also, association between serum vitamin D metabolites and quintiles of wholePTH or FGF23 values were analyzed by one-way ANOVA (analysis of variance), followed by Dunnett's test. All statistical analyses were performed using the Stat View V system (Abacus Concepts, Berkeley CA) and JMP Pro 12 (SAS Corporation, Cary, North Carolina, United States) on a Windows computer. P values < 0.05 were considered to indicate statistical significance.
